Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Emcure Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:544210NSE Symbol: EMCUREP/E(TTM):66.91
ISIN Demat:INE168P01015Div & Yield %:0.2EPS(TTM):22.83
Book Value(Rs):169.5059542Market Cap ( Cr.):28958.15Face Value(Rs):10
    Change Company 
Date Headline
24-Dec-25 Indices edge higher in early trade; breadth strong
22-Dec-25 Emcure launches semaglutide injection Poviztra® in India
18-Nov-25 Volumes spurt at Mphasis Ltd counter
11-Nov-25 Emcure Pharmaceuticals consolidated net profit rises 25.13% in the September 2025 quarter
10-Nov-25 Novo Nordisk India partners with Emcure launch Poviztra® in India
04-Nov-25 Emcure Pharmaceuticals to hold board meeting
28-Oct-25 Volumes jump at Aditya Birla Capital Ltd counter
17-Oct-25 Emcure Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Credit Rating
10-Oct-25 Emcure Pharmaceuticals' Kadu unit clears USFDA inspection
08-Oct-25 Emcure Pharmaceuticals Ltd - Emcure Pharmaceuticals Limited - Updates
<< < 1 2 3 4   > >>